Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity

NCT00197249 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1034

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis A

Interventions

BIOLOGICAL: Combined Vi polysaccharide typhoid vaccine and hepatitis A vaccine- Hepatyrix

Sponsor

GlaxoSmithKline